相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metformin inhibits inflammatory angiogenesis in a murine sponge model
D. O. Xavier et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Mitogenic action of insulin: friend, foe or 'frenemy'?
B. Draznin
DIABETOLOGIA (2010)
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin
Piotr J. Wysocki et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
Sulphonylureas and cancer: a case-control study
Matteo Monami et al.
ACTA DIABETOLOGICA (2009)
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ER alpha negative MDA-MB-435 breast cancer model
Kathryn N. Phoenix et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study
Jonathan L. Wright et al.
CANCER CAUSES & CONTROL (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration
Kerstin Lang et al.
CELL COMMUNICATION AND SIGNALING (2009)
Does diabetes therapy influence the risk of cancer?
U. Smith et al.
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Metformin: diamonds are forever
N. Papanas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Do Diabetes Drugs Modify the Risk of Pancreatic Cancer?
Yu-Xiao Yang
GASTROENTEROLOGY (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
Metformin As an Addition to Conventional Chemotherapy in Breast Cancer
Tal Grenader et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
If Mammalian Target of Metformin Indirectly Is Mammalian Target of Rapamycin, Then the Insulin-Like Growth Factor-1 Receptor Axis Will Audit the Efficacy of Metformin in Cancer Clinical Trials
Alejandro Vazquez-Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Metformin in Breast Cancer: Time for Action
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Xu Huang et al.
BIOCHEMICAL JOURNAL (2008)
The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
Mahvash Zakikhani et al.
CANCER PREVENTION RESEARCH (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Obesity and cancer
Tobias Pischon et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
E. Friberg et al.
DIABETOLOGIA (2007)
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
Maria E. Ramos-Nino et al.
BMC MEDICINE (2007)
The energy sensing LKB1-AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis
Jiyong Liang et al.
NATURE CELL BIOLOGY (2007)
Diabetes mellitus and risk of bladder cancer: a meta-analysis
S. C. Larsson et al.
DIABETOLOGIA (2006)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Obesity and cancer risk: the role of the insulin-IGF axis
Andrew G. Renehan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
VN Anisimov et al.
EXPERIMENTAL GERONTOLOGY (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
YX Yang et al.
GASTROENTEROLOGY (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
